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We examined histone phosphorylation and their effects on glucocorticoid receptor (GR)-mediated activation of the mouse mammary tumor
virus promoter (MMTV) in synchronized cells. In vivo protein expression studies suggest that both histones H1 and H3 are highly phosphorylated
in mitotic-arrested cells in which GR is unable to remodel chromatin and recruit transcription factor NF1 to the promoter. Postmitotic cells show
an open chromatin structure and efficient binding of NF1 to the promoter accompanied by reversing histone H1 and H3 phosphorylation level. In
contrast, the acetylation status of histone H3 and H4 did not change in either condition. These results suggest that hyperphosphorylation of histone
H1 and H3 leads to inhibition of GR-mediated chromatin remodeling and inactivation of MMTV by preventing the association of transcription
factors to the promoter in vivo.
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DNA in eukaryotic nuclei is efficiently organized into
chromatin (van Holde, 1988). Nucleosomes, the structural units
of chromatin, are composed of 146 bp of DNAwound around an
octamer of four core histone protein H2A, H2B, H3, H4 (Luger
et al., 1997). With the addition of the linker histone H1, binding
to the linker DNA between nucleosomes, one begins the
assembly of a higher order of chromatin organization
(Ramakrishnan, 1997). This composition can make chromatin
a dynamic but highly repressive structure that limits the access
of DNA binding proteins to DNA (Wolffe and Kurumizaka,
1998; Workman and Kingston, 1998). Thus, chromatin⁎ Corresponding author. Akira Innate Immunity Project, Exploratory Research
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doi:10.1016/j.virol.2005.12.034remodeling is an essential step for efficient transcription of
many eukaryotic genes. Numerous studies support a strong
link between transcriptional regulation and the alteration of
chromatin structure through acetylation, methylation, or phos-
phorylation of histones (Fischle et al., 2003; Kouzarides, 2002).
It has been reported that addition of linker histone H1 to the
substrate greatly inhibited the chromatin remodeling activities
by hSWI/SNF, xMi-2, and xACF complexes and remodeling by
ySWI/SNF could be rescued by the incorporation of histone H1
phosphorylation initiated by the cell cycle-dependent kinase
Cdc2 (Horn et al., 2002). To address the possible connection
between histone phosphorylation in cell cycle and structural
changes of chromatin, we used a glucocorticoid receptor (GR)
inducible MMTV promoter integrated into mouse carcinoma
cells (1471.1 cells) as a model system where chromatin
structure and gene expression have been intimately linked
(Archer et al., 1995). In the absence of glucocorticoid, the stably
integrated MMTV promoter is incorporated into six regularly
positioned nucleosomes (Richard-Foy and Hager, 1987). The
2 Rapid Communicationregion of the promoter occupied by the second nucleosome
(Nuc-B) contains the hormone responsive element (HRE) to
which GR binds as well as target sites for transcription factors
such as nuclear factor 1 (NF1) and octamer transcription factors
(Hsiao et al., 2002). Glucocorticoid treatment promptly induces
remodeling of the chromatin, recruits transcription factor
nuclear factor 1 (NF1), and activates transcription. By using
this system, we have previously shown a connection between
Cdk2 kinase-mediated histone H1 phosphorylation and the
transcriptional competence of the MMTV promoter (Bhatta-
charjee et al., 2001).
Similarly increased histone H3 phosphorylation on serine 10
during mitosis seems to be essential for proper chromosomal
condensation (Hendzel et al., 1997). Interestingly, the signifi-
cance of H3 phosphorylation on serine 10 has also been
implicated in the induction of transcription during the heat
shock response (Nowak and Corces, 2000), and also an elevated
level of H1 and H3 phosphorylation is thought to be associated
with decondensed chromatin and aberrant gene expression in
oncogene transformed fibroblast (Chadee et al., 2002). This
raises the intriguing possibility that H3 phosphorylation is
involved in two apparently structurally distinct processes, i.e.,
chromosome condensation and gene transcription. By utilizingFig. 1. Synchronization of 1471.1 cells. (A) Cells were treated by nocodazole, mitoti
5 h to release from mitotic phase (postmitotic) as described previously. Cells were fixe
represent the cells in G0–G1, S, and G2-M. A total of 104 nuclei, per sample, analyze
vivo. Commercially purified histone H1 as a running control (lane 1), untreated cells
mitotic cells treated with dexamethasone for 1 h (lane 5), postmitotic (lane 6), and pos
separated on a 16% acrylamide acid–urea gel, transferred to nitrocellulose membr
antibody (Upstate Biotechnology). Equal loading of protein was confirmed by stain
Percentage of phosphorylated histone H1 in chromatin. Histones were separated on
Western blot products detected by anti-phosphorylated H1 were quantified using Imsynchronized mouse mammary cells, we analyzed the effect of
cell cycle-dependent in vivo phosphorylation of histone H1 and
H3 on promoter structure of MMTV.
Results
Increased histone H1 phosphorylation in metaphase-arrested
1471.1 cells
For synchronization, 1471.1 cells were incubated with
nocodazole, and metaphase-arrested cells were collected by
gentle pipetting and shaking. For comparative analysis, mitotic
cells were then washed extensively and fed fresh medium to
allow cells to move forward from M phase and reenter the cell
cycle. These non-mitotic cell populations are termed as
postmitotic cells for simplicity. After 16 h of treatment with
nocodazole, there was a sharp increase in the M phase
population (Fig. 1A), from 17% in asynchronous cells to 89%
in nocodazole-arrested cells. Flow cytometry analysis showed
that 5 h after the release from the nocodazole block, cells
previously accumulating in M phase progressed normally
through the cell cycle (Fig. 1A). As shown in Fig. 1B, untreated
control as well as postmitotic cells contained similar amounts ofc cells were collected, washed extensively with fresh medium and incubated for
d, stained with PI, and examined for DNA content by flow cytometer. The peaks
d. (B) Histone H1 is hyperphosphorylated in nocodazole-arrested 1471.1 cells in
(lane 2), treated with dexamethasone (10−7 M) for 1 h (lane 3), mitotic (lane 4),
tmitotic cells treated with dexamethasone for 1 h (lane 7). Histones (30 μg) were
ane, and analyzed by Western blot using a polyclonal anti-phosphorylated H1
ing the blot with amido black dye to reveal total H1 present (lower panel). (C)
a 16% acrylamide acid-urea gel, transferred to nitrocellulose membrane, and
age Quant software.
Fig. 2. Phosphorylation and acetylation status of histone H3 in mitotic and
postmitotic cells. Untreated (lane 1), treated with dexamethasone (10−7 M) for 1
h (lane 2), mitotic (lane 3), and postmitotic (lane 4) cells. Total histones (10 μg)
were subjected to SDS-PAGE and transferred to nitrocellulose membrane before
immunoblotting with (A) primary antibodies specific to acetylated histone H3
and (B) primary antibodies specific to phosphorylated histone H3 as indicated in
the figure. Equal loading of protein was confirmed by staining the blot with
amido black dye (lower panel).
Fig. 3. GR-induced restriction enzyme hypersensitivity of the MMTV chromatin
in vivo. (A) Schematic of the MMTV promoter indicating the Nuc-B position,
sites of cleavage by restriction enzymes, and the NF1 binding site. (B) MMTV
promoter in mitotic cells is resistant to hormone-mediated chromatin
remodeling. Asynchronous (lane 1), treated with dexamethasone (10−7 M) for
1 h (lane 2), mitotic (lane 3), mitotic cells treated with dexamethasone for 1
h (lane 4), postmitotic (lane 5), and postmitotic cells treated with dexamethasone
for 1 h (lane 6). Genomic DNA was purified and then digested to completion
with HaeIII in vitro. This provided an internal standard for accessing the extent
of in vivo cleavage and confirmed that equivalent amounts of DNAwere used in
each reaction. 10 μg of each sample was analyzed by reiterative primer exten-
sion with Taq polymerase and a 32P-labeled single stranded primer (MMTV#22,
5′-CTGGAAAGTGAAGGATAAGTGACGA-3′) corresponding to +60 to +84
portion of the MMTV promoter. The purified extension products were separated
on 7% polyacrylamide denaturing gels and exposed to film. Lane M is the size
standard φX174 cut with HaeIII. The arrows indicate HaeIII and SstI cleavage
products. (C) In vivo detection of NF1 binding to the MMTV promoter. Cells
were treated as described in panel B. HaeIII (1000 U/ml) and Exonuclease III
(625 U/ml) were then used to detect 5′ boundaries of transcription factors on the
MMTV promoter. DNA was purified, and single-stranded overhangs were
removed with Mung bean nuclease. All samples were digested to completion
with AlwnI prior to analysis by reiterative primer extension with Taq polymerase
using a 32P-labeled primer, MMTV #22. The purified extension products were
analyzed on 7% polyacrylamide denaturing gels and exposed to film. Lane M is
the size standard φX174 cut with HaeIII.
3Rapid Communicationphospho-H1 protein (∼32–45%) of the total histone H1 (Figs.
1B and C, lane 2, 3 and 6, 7). In contrast, histone H1 from
mitotic cell showed the highest level of phosphorylation status
(∼78% of total histone H1, Fig. 1C) (Fig. 1B, lanes 4, and 5).
Cells treated with hormone for an hour, which maximizes
transcriptional activity from the MMTV promoter, had levels of
phosphorylated histone H1 protein similar to those of non-
treated cells (Fig. 1B, lanes 3, 5, and 7). The levels of total
histone H1 in the cells were essentially unchanged under all
conditions (Fig. 1B, lower panel).
Acetylation status of Histone H3 is unchanged but H3 is
hyperphosphorylated in M phase
The relationship between transcriptional activity and acety-
lation–deacetylation of core histones H3 and H4 has been
studied extensively, and in general, acetylation activates
transcription, whereas deacetylation leads to transcriptional
silencing (Cheung et al., 2000). However, the MMTV promoter
is a notable exception to this paradigm as its transactivation has
been linked to the deacetylation of core histones at the promoter
and exposure to TSA, the histone deacetylase inhibitor, blocks
hormone-dependent activation (Wilson et al., 2002). We next
examined the expression levels of acetylated histone H3 and
observed no significant change in acetylation status in untreated
control, mitotic, and postmitotic cells (Fig. 2A). In contrast,
mitotic cells showed a remarkable increase in histone H3
phosphorylation that disappeared promptly when cells were
allowed to proceed through the cell cycle (Fig. 2B compare
lanes 3 and 4).Glucocorticoid receptor is unable to remodel chromatin and
MMTV promoter activation in mitotic cells
Within the MMTV promoter, the second nucleosome (nuc-
B) encompasses the binding site for the transcription factor NF1
as well as the binding sites for the GR (Richard-Foy and Hager,
1987). The glucocorticoid induces disruption of nuc-B, which
allows access of transcription factors, makes the promoter
4 Rapid Communicationhypersensitive to digestion by restriction endonucleases in this
region (Archer et al., 1991). To assess the differences of
transcriptional activity of the MMTV promoter, if any, in the
cells that contained different level of phospho-H1 and phospho-
H3, we performed hypersensitivity assay and NF1 loading
experiment on MMTV promoter in similarly treated cells. Figs.
3B and C showed that GR is unable to remodel chromatin or
recruit NF1 to the promoter of mitotic cells that concomitantly
express higher amounts of phosphorylated H1–H3 than
postmitotic cells. Compared with untreated cells, dexametha-
sone treatment for 1 h resulted in substantially elevated cleavage
(∼6- to 7-folds) by the restriction enzyme SstI that cleaves
within nuc-B (Fig. 3B, compare lanes 1 and 2). Postmitotic cells
showed an equal level of activation of the promoter as control
cell populations (Fig. 3B, compare lanes 2 and 6). However, in
metaphase cells, accessibility of the restriction enzyme Sst1 to
the promoter was completely blocked and showed no sensitivity
to hormone action (Fig. 3B, compare lanes 2 and 4). In parallel
with the chromatin remodeling assayed by restriction enzyme
hypersensitivity, treatment of naive cells with dexamethasone
for 1 h increased the level of bound NF1 (Fig. 3C, compare
lanes 1 and 2). However, NF1 binding was reduced greatly in
cells previously treated with nocodazole and subsequently
induced by dexamethasone (Fig. 3C compare lanes 2 and 4).
When cells that showed diminished NF1 binding and repressive
nucleosome B (Lane 4) were allowed to be progress into the
cell cycle, NF1 binding, in response to dexamethasone, was
restored to levels seen in asynchronous cells (Fig. 3C compare
lanes 2 and 6).
Discussion
Previously, we have reported that the inhibition of cdk2
activity in either hormone refractory mouse cells or cells
treated with cdk2 inhibitors promotes the dephosphorylation
of histone H1 which modifies MMTV chromatin structure in
such a way that the GR is neither able to remodel chromatin
nor recruit transcription factors to the promoter (Bhattachar-
jee et al., 2001, Lee and Archer, 1998). It has been
postulated that phosphorylation of histone H1 decreases its
net positive charge and repels it from negatively charged
DNA. This depletion or removal of histone H1 from
nucleosomes may then lead to a structural reorganization of
chromatin providing access to transcription factors involved
in replication and transcription (Roth and Allis, 1992).
However, contrary to the hypothesis of the association of
H1 and H3 hyperphosphorylation with condensed chromatin
during mitosis Bradbury, 1992), their roles have also been
implicated in decondensing chromatin structure, induction of
transcription and gene expression in oncogene-transformed
fibroblast as well as during the heat shock response (Nowak
and Corces, 2000). Given that transcriptional activities take
place within condensed chromatin, the question remains how
do large complexes used in chromatin remodeling, repair,
transcription, and translation able to gain access to the DNA
within such restrictive chromatin environment (Wolffe and
Kurumizaka, 1998). Although an ATP-dependent SWI/SNF-B remodeling complex is found to be localized to spindle
poles and kinetochores of mitotic chromosome (Xue et al.,
2000), it is possible that this complex is involved in opening
the compact chromatin for the transcription machinery. But
for MMTV, the elevated levels of histone H1 and H3
phosphorylation in mitotic chromatin may be responsible for
the highly condensed chromatin where GR-mediated recruit-
ment of chromatin remodeling complexes for the initiation
of transcription are compromised (Hebbar and Archer,
2003).
Within the context of the MMTV promoter, our experiments
suggest that a moderate amount of histone H1 phosphorylation
has an important role in the induction of transcription from
MMTV promoter. By increasing the level of H3 phosphoryla-
tion, M phase cells establish a closed chromatin structure that
blocks NF1 binding to the MMTV, suggesting that these events
are functionally linked. The acetylation of core histones
including histone H3 and coupled covalent modifications such
as phosphorylation–acetylation of histone H3 has been linked
to gene transcription (Strahl and Allis, 2000). We were therefore
examined if acetylation status of histone H3 changes in cell
cycle which might contribute to the modulation of MMTV
activities in mitotic and postmitotic cells. In vivo protein
expression studies confirm little differences in acetylated
histone H3 distribution in these cells (Fig. 2A), thus suggests
that change in this modification may not be required in
hormonal regulation for MMTV. The moderate reduction of H1
phosphorylation and dramatic loss of and H3 hyperphosphor-
ylation at transcriptionally active postmitotic cells suggests that
modulating the phosphorylation status of H1 and H3 may be
critical to establishing a chromatin structure accessible to the
GR to initiate transcription from the MMTV promoter. The
availability of model systems with well-defined chromatin
architectures such as the MMTV promoter will be invaluable in
elucidating the roles of histone phosphorylation in broad range
of cellular functions including the control of cell cycle
progression, chromatin condensation, and the regulation of
transcription within normal and cancer cells.
Materials and methods
Cell culture and cell synchronization
C127 mammary carcinoma cells (1471.1 cells) stably
maintain ∼200 copies of a bovine papilloma virus (BPV)
vector with the MMTV promoter attached to the bacterial
chloramphenicol acetyltransferase (CAT) gene (Archer et al.,
1991). Cells were grown at 37 °C with 5% CO2 in Dulbecco's
modified Eagle's medium containing 10% fetal bovine serum.
For synchronization, 1471.1 cells were cultured in the presence
of 50 ng/ml nocodazole (Sigma) for 16 h, and metaphase-
arrested cells were collected by gentle pipetting and shaking
(Bhattacharjee et al., 1996). The mitotic cells were then washed
extensively and reseeded in fresh medium for 5 h to release
from metaphase (postmitotic). Cells were treated with dexa-
methasone (10−7 M) for the time period indicated in the figure
legends.
5Rapid CommunicationCell cycle analysis
For the analysis of DNA content by flow cytometry, cells
were trypsinized, washed in PBS, and stained by Propidium
Iodide (PI) using the CycleTEST and DNA reagent kits (Becton
Dickinson, San Jose, CA). This method involves dissolving the
cell membrane, eliminating nuclear proteins, stabilizing chro-
matin, and staining by PI. Fluorescent light emitted (at 585 nm)
from PI-stained nuclei was detected by the FACScan's
fluorescence 2 (FL2) detector. Percentage of cells (from a total
of 104 cells) at different phases of the cell cycle was determined
using the FlowJo 4.5.2 software and the Watson analysis.
Immunoblotting
For immunoblot, cells previously treated with or without
hormone and/or nocodazole, were washed with cold PBS, and
pelleted. The cells were lysed in buffer X + BSA (100 mM Tris–
HCl, pH 8.5, 250 mM NaCl, 1% (v/v) NP-40, 1 mM EDTA, 1
μg/ml aprotinin, 2 mg/ml BSA). Whole cell protein lysates were
solubilized in loading buffer, subjected to SDS-PAGE, and
transferred to nitrocellulose followed by incubation with
antibodies mentioned in figure legends.
Extraction of total histones and separation by acid urea gel
electrophoresis
Total histones were prepared from nuclei of the cells above
by H2SO4 extraction. Acid soluble proteins were prepared by
resuspending nuclei in 0.4N H2SO4 at 4 °C for 1 h. The
suspension was centrifuged, and basic proteins were precipi-
tated from the supernatant overnight at −20 °C by addition of 1
ml of acetone. Proteins were collected by centrifugation, air
dried, and dissolved in 50 μl solution contained 0.9 M acetic
acid and 25 μl of 75% sucrose. Histones (30 μg) were separated
on a 16% acrylamide acid–urea gel (0.75 mm thick, 12 cm long)
as previously described (Panyim and Chalkley, 1969), trans-
ferred to nitrocellulose membrane (Amersham) for 24 h at
50 V and 4 °C in a transfer buffer (25 mM Tris–HCl, 0.19 M
glycine, and 20% methanol), and analyzed by Western blot
using a polyclonal anti-phosphorylated H1 antibody (Upstate
Biotechnology).
In vivo restriction enzyme hypersensitivity analysis
Nuclei were isolated and digested with restriction endonu-
cleases. Genomic DNA was purified by phenol/chloroform
extraction and then digested to completion with HaeIII in vitro.
This provided an internal standard for accessing the extent of in
vivo cleavage and confirmed that equivalent amounts of DNA
were used in each reaction. 10 μg of each sample was analyzed
by reiterative primer extension with Taq polymerase and a 32P-
labeled single stranded primer (MMTV#22, 5′-CTGGAAAGT-
GAAGGATAAGTGACGA-3′) corresponding to +60 to +84
portion of the MMTV promoter. The purified extension
products were separated on 7% polyacrylamide denaturing
gels and exposed to film.In vivo analysis of transcription factor loading
Isolated nuclei were digested by HaeIII (1000 U/ml) and
Exonuclease III (625 U/ml) to detect 5′ boundaries of
transcription factors on the MMTV promoter. DNA was
purified, and single-stranded overhangs were removed with
Mung bean nuclease. All samples were digested to completion
with AlwnI prior to analysis by reiterative primer extension with
Taq polymerase using a 32P-labeled primer, MMTV #22. The
purified extension products were analyzed on 7% polyacryl-
amide denaturing gels and exposed to film.
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